John Wickersham
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Virology top 10%
Papers in
-
- Biochemical and Molecular Research 2
- Angiogenesis and VEGF in Cancer 2
- RNA and protein synthesis mechanisms 2
-
- HIV/AIDS drug development and treatment 2
- Co-authors
- Zdeněk Hostomský (2 shared papers)Zuzana Hostomska (2 shared papers)Ellen W. Moomaw (2 shared papers)Tsuyoshi Adachi (2 shared papers)Noriyuki Habuka (2 shared papers)Hans E. Parge (2 shared papers)Robert A. Love (2 shared papers)Chao‐Zhou Ni (2 shared papers)
- Journals
- The American Historical Review (2 papers)Structure (2 papers)The Classical World (1 paper)Cell (1 paper)Protein Science (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
John Wickersham
10 papers receiving 678 citations
Peers
Comparison fields: 5 of 82
- Hepatology 340
- Virology 34
- Infectious Diseases 126
- Epidemiology 216
- Radiology, Nuclear Medicine and Imaging 140
Countries citing papers authored by John Wickersham
This map shows the geographic impact of John Wickersham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Wickersham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Wickersham more than expected).
Fields of papers citing papers by John Wickersham
This network shows the impact of papers produced by John Wickersham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Wickersham. The network helps show where John Wickersham may publish in the future.
Co-authors
The 25 scholars most cited alongside John Wickersham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 398 | |
| 2 | 1999 | 161 | |
| 3 | 1995 | 81 | |
| 4 | 1998 | 34 | |
| 5 | 1996 | 18 | |
| 6 | 1996 | 15 | |
| 7 | PF-00337210, a potent, selective and orally bioavailable small molecule inhibitor of VEGFR-2 | 2007 | 7 |
| 8 | 1995 | 7 | |
| 9 | 1976 | 2 | |
| 10 | 1994 | 1 |
About John Wickersham
John Wickersham is a scholar working on Molecular Biology, Infectious Diseases, Anthropology, Ecology and Genetics, having authored 10 papers that have together received 724 indexed citations. Recurring topics across this work include Classical Antiquity Studies (2 papers), Hepatitis C virus research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), HIV/AIDS drug development and treatment (2 papers), Biochemical and Molecular Research (2 papers), Angiogenesis and VEGF in Cancer (2 papers), RNA and protein synthesis mechanisms (2 papers) and Bacteriophages and microbial interactions (2 papers). The work is most often cited by research in Hepatology (340 citations), Virology (34 citations), Infectious Diseases (126 citations), Epidemiology (216 citations) and Radiology, Nuclear Medicine and Imaging (140 citations). John Wickersham has collaborated with scholars based in United States and Japan. Frequent co-authors include Zdeněk Hostomský, Zuzana Hostomska, Ellen W. Moomaw, Tsuyoshi Adachi, Noriyuki Habuka, Hans E. Parge, Robert A. Love, Chao‐Zhou Ni, Kathryn R. Ely and David S. Peabody. Their work appears in journals such as The American Historical Review, Structure, The Classical World, Cell and Protein Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.